To include your compound in the COVID-19 Resource Center, submit it here.

GSK3A inhibition restores asparaginase sensitivity in resistant ALL, AML

DISEASE CATEGORY: Cancer

INDICATION: Acute lymphoblastic leukemia (ALL); acute myelogenous leukemia (AML)

Cell culture and mouse studies suggest inhibiting GSK3A could

Read the full 190 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE